Sangamo Announces ASGCT 2024

Clinical Trials
Our approach to clinical trials

Sangamo is conducting several clinical trials to evaluate the safety, tolerability, and potential efficacy of its genomic medicines, some of which we lead and some of which are led by our global pharmaceutical company collaboration partners.

Medical advances depend on the participation of patients in clinical studies. We are grateful to all participants in our clinical trials, their friends and families, who make a positive contribution towards a better future for all people living with severe diseases.

Learn more about our clinical trials below.


Ongoing Studies (Not Currently Recruiting)